Sarepta Therapeutics, Inc. (34) | Human Resources (11)

Browse by Subcategory

Recent Contracts

Amendment No. 2 to the Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on June 3, 2022)
Separation Agreement and General Release, signed November 15, 2021 between Sarepta Therapeutics, Inc. and Dr. Gilmore O'Neill (Filed With SEC on March 1, 2022)
Separation and Consulting Agreement and General Release between David T. Howton Jr. and Sarepta Therapeutics, Inc (Filed With SEC on March 1, 2021)
Form of Severance Letter Agreement entered into between Sarepta Therapeutics, Inc. and each of Sandesh Mahatme, David Tyronne Howton, Jr. and Alexander Bo Cumbo (Filed With SEC on May 8, 2019)
Form of Change in Control and Severance Agreement entered into between Sarepta Therapeutics, Inc. and each of Sandesh Mahatme, David Tyronne Howton, Jr. and Alexander Bo Cumbo (Filed With SEC on May 8, 2019)
Form of Performance-Based Restricted Stock Unit Award Agreement under Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on May 4, 2022)
Separation Agreement and General Release between Sandesh Mahatme and Sarepta Therapeutics, Inc (Filed With SEC on August 5, 2020)
Amendment No. 1 to the Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on June 8, 2020)
Amendment No. 2 to the Sarepta Therapeutics, Inc. 2014 Employment Commencement Incentive Plan (Filed With SEC on February 21, 2020)
Sub-Plan for Japan under the Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on August 7, 2019)
Sub-Plan for Japan under the Sarepta Therapeutics, Inc. 2014 Employment Commencement Incentive Plan (Filed With SEC on August 7, 2019)